Digital Animal Technology Replacement (DART): An Animal Testing Alternative

Commit to animal cruelty-free testing


With the FDA passing the Modernization Act 2.0 in December 2022 and the European Parliament adopting a resolution to phase out animal testing in September 2022, the need for the shift is more urgent than ever.

DART enables you to predict and manage safety concerns such as neurovirulence, neurotoxicity, and sterility in the workflow during the R&D, clinical trials, and production phases without involving animal experimentation.

human-psy

Higher relevance to human physiology 

no-animals

No animal experimentation or biopsies

cost-eff

Cost effective modern approach

integrate

 Enhanced prediction accuracy with ML models

icons 6

Seamless integration into the company’s existing Quality Check workflow

time-eff

Reduction in testing time drastically

Get Human Relevant Drug Testing Results

Get Human-Relevant Drug Testing Results


DART uses advanced technologies that apply deep-learning neural network algorithms to generate highly accurate human-relevant scientific data. 

Change the traditional way of safety and efficacy assessments



An in-vitro platform-1

An in-vitro platform that uses a human micro physiological system created from an ethically sourced biobank.

digital workstation solution-1

A digital workstation solution to predict safety concerns by comparing with benchmark patterns derived through segmentation model training to provide accurate predictions.

Accelerate Drug Discovery with Dart



Batch Testing

number-circle-one-thinBatch Testing


Prediction of neurovirulence and sterility in the vaccine production workflow

Drug Discovery

number-circle-two-thin
Drug Discovery 


Prediction of neurovirulence in viral vaccine development process

Antivenom Efficacy

number-circle-three-thinAntivenom Efficacy


Prediction of antivenom potency and effectiveness

Cell-Therapy

number-circle-four-thin
Cell-Therapy 


Prediction of CAR-T cell therapy-induced neurotoxicity

DART-br-thumb